Combination of genioglossus advancement by non-trephine technic with uvulopalatopharyngoplasty for treatment of obstructive sleep apnea-hypopnea syndrome
10.3760/cma.j.issn.1673-0860.2009.10.009
- VernacularTitle:颏舌肌前移舌骨悬吊联合悬雍垂腭咽成形术的初步应用
- Author:
Shi-Cai CHEN
1
;
Song SHI
;
Hong-Liang ZHENG
;
Dong-Hui CHEN
;
Min-Hui ZHU
;
Fei LIU
;
Hai-Hang TANG
;
Kai WANG
Author Information
1. 第二军医大学附属长海医院
- Keywords:
Sleep apnea;
obstructive;
Otorhinolaryngoiogic surgical procedures;
Oral surgical procedures;
Chin;
Hyoid bone
- From:
Chinese Journal of Otorhinolaryngology Head and Neck Surgery
2009;44(10):815-818
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the efficacy and reliability of genioglossus advancement and hyoid suspension with non-trephine technic (GAHM) and uvulopalatopharyngoplasty (UPPP) for surgical obstructive sleep apnea-hypopnea syndrome treatmen. Methods Twenty-six patients (4 female and 22 male) were classified as moderate and severe cases in terms of apnea hypopnea index (AHI) and Friedman classification in the present study. All cases patients underwent genioglossus advancement and hyoid suspension with non-trephine technic Uvulopalatopharyngoplasty UPPP. Pre- and postoperative polysomnography and Epworth sleepiness scale were performed to assess the therapeutic outcomes. Results The whole operation time ranged from 120-180 minutes. The average amount of bleeding in genioglossus advancement was about 50-100 ml. There were no severe complications during and after the operation. All the cases were followed up to one year. After surgery, AHI was decreased in both group eases, (42.9±6.6 vs 16.2±5.7) in the severe group, and 21.3±4. 4 vs 11.3±5.2 (x±s) in the moderate group. With success defined as AHI decreased by more than 50 per cent after swgery, the total success rate in moderate and severe group was 83.3% and 91.7%, respectively (P<0.01). Furthermore, the success rate of the moderate group was higher than those of the severe group (P<0.01). Conclusion GAHM combined with UPPP may be beneficial for the moderate and severe OSAHS patients with oropharyngeal and hypopharyngeal obstruction.
